| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $1.4B | $1.3B | $0.3B | $0.4B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.3B | $0.2B | $0.0B | $0.1B | $0.0B | $0.3B |
| EPS (Basic) | $9.14 | $7.80 | $7.13 | $4.41 | $0.51 | $1.62 | $1.32 | $8.98 |
| EPS (Diluted) | $9.12 | $7.78 | $7.12 | $4.35 | $0.50 | $1.59 | $1.30 | $8.83 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.0B | $12.3B | $11.3B | $10.1B | $8.9B | $8.3B | $7.6B | $7.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $0.4B | $0.5B | $0.3B | $0.3B | $0.2B | $0.1B | $0.3B |
| Total Liabilities | $14.4B | $9.9B | $9.1B | $8.0B | $7.0B | $6.5B | $5.8B | $5.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.8B | $2.4B | $2.3B | $2.0B | $2.0B | $1.8B | $1.8B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.5B | $0.5B | $0.4B | $0.5B | $0.5B | $0.5B |
| Investing Cash Flow | $-1.0B | $-1.4B | $-1.2B | $-0.9B | $-0.9B | $-0.4B | $-0.7B | $-0.4B |
| Capital Expenditures | — | — | $1.7B | $1.3B | $0.9B | $0.7B | $0.9B | $0.6B |
| Financing Cash Flow | $4.9B | $0.8B | $0.8B | $0.5B | $0.4B | $0.0B | $-0.0B | $-0.1B |